Evidence map›Paper›PMID 33208503›Full record

ArticleScience translational medicine2020

A

Jan Claesen, Jennifer B Spagnolo, Stephany Flores Ramos, Kenji L Kurita, Allyson L Byrd, Alexander A Aksenov, Alexey V Melnik, Weng R Wong, Shuo Wang, Ryan D Hernandez and 7 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Interaction BetweenCurrent pharmaceutical biotechnology · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. The human skin microbiome in health.Journal of the American Academy of Dermatology · 2025
    Review
  20. Topographical variations in the skin barrier and their role in disease pathogenesis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Jan ClaesenDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-0755-7974
Jennifer B SpagnoloMicrobiology, Forsyth Institute, Cambridge, MA 02142, USA.
Stephany Flores RamosMicrobiology, Forsyth Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-1918-9769
Kenji L KuritaDepartment of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.ORCID 0000-0002-6979-7033
Allyson L ByrdMicrobial Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-9064-3621
Alexander A AksenovCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, and Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-9445-2248
Alexey V MelnikCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, and Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-4645-8880
Weng R WongDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-2940-7344
Shuo WangDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08540, USA.ORCID 0000-0002-8111-2850
Ryan D HernandezDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-5249-504X
Mohamed S DoniaDepartment of Molecular Biology, Princeton University, Princeton, NJ 08540, USA.ORCID 0000-0002-9604-2912
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, and Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-3003-1030
Heidi H KongDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-4424-064X
Julia A SegreMicrobial Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-6860-348X
Roger G LiningtonDepartment of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.ORCID 0000-0003-1818-4971
Michael A FischbachDepartment of Bioengineering and ChEM-H, Stanford University, Stanford, CA 94305, USA. fischbach@fischbachgroup.org katherine.lemon@bcm.edu.ORCID 0000-0003-3079-8247
Katherine P LemonMicrobiology, Forsyth Institute, Cambridge, MA 02142, USA. fischbach@fischbachgroup.org katherine.lemon@bcm.edu.ORCID 0000-0003-1542-1679
University of Montana · USNational Human Genome Research Institute · USPrinceton University · USSimon Fraser University · CAUniversity of California, San Francisco · USBoston Children's Hospital · USCleveland Clinic Lerner College of Medicine · USForsyth County Schools · USHarvard University · USNational Institutes of Health · USStanford University · US

Funding

Urgent Covid-19 Revision to the Center for High-Throughput Functional Annotation of Natural ProductsU41AT008718 · NCCIH · UT SOUTHWESTERN MEDICAL CENTER · PI CECH, NADJA B, LININGTON, ROGER G · 2015 to 2024
$10.1M
A complete map of the top 100 molecules from the gut microbiomeDP1DK113598 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2020
$5.5M
Antibiotics from nose and throat commensals that impact pathogen colonizationR01AI101018 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI FISCHBACH, MICHAEL ANDREW, LEMON, KATHERINE PAIGE · 2012 to 2021
$4.4M
Identification and characterization of natural products from the human microbiotaR01DK110174 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FISCHBACH, MICHAEL ANDREW · 2016 to 2019
$1.4M
NCCIH NIH HHS U41 AT008718NIAID NIH HHS R01 AI101018NIDDK NIH HHS DP1 DK113598NIDDK NIH HHS R01 DK110174
6 · The paper itself

Abstract

The composition of the skin microbiota varies widely among individuals when sampled at the same body site. A key question is which molecular factors determine strain-level variability within sub-ecosystems of the skin microbiota. Here, we used a genomics-guided approach to identify an antibacterial biosynthetic gene cluster in

Indexed as

Hair FollicleMicrobiotaAnti-Bacterial AgentsHumansPropionibacterium acnesSkinAnti-Bacterial Agents

Identifiers

PMID33208503
PMCPMC8478231
OpenAlexW3106031838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.